Showing results (51-60 of 156) with videos related to
Sort By:
Pageof 16
Transfusion|February 11, 2017
Patient age and number of apheresis days may predict development of secondary myelodysplastic syndrome and acute myelogenous leukemia after high-dose chemotherapy and autologous stem cell transplantation for lymphomaIsabell Ge, Rima M Saliba, Farzaneh Maadani, et al.Bone Marrow Transplantation|May 9, 2017
B-cell activating factor (BAFF) plasma level at the time of chronic GvHD diagnosis is a potential predictor of non-relapse mortalityR M Saliba, S Sarantopoulos, C L Kitko, et al.Experimental Hematology|January 17, 2004
Nonablative allogeneic stem cell transplantation for chronic lymphocytic leukemia: impact of rituximab on immunomodulation and survivalIssa F Khouri, Ming-Sheng Lee, Rima M Saliba, et al.Biochemical and Biophysical Research Communications|August 2, 2005
Mycobacterium leprae induces NF-kappaB-dependent transcription repression in human Schwann cellsRenata M S Pereira, Teresa Cristina Calegari-Silva, Maristela O Hernandez, et al.BMC Research Notes|June 15, 2012
A framework to identify gene expression profiles in a model of inflammation induced by lipopolysaccharide after treatment with thalidomideRenata T Paiva, Alessandra M Saliba, Tatiana O Fulco, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 24, 2007
Results of a retrospective single institution analysis of targeted skeletal radiotherapy with (166)Holmium-DOTMP as conditioning regimen for autologous stem cell transplant for patients with multiple myeloma. Impact on transplant outcomesAnna V Christoforidou, Rima M Saliba, Patricia Williams, et al.Transfusion|September 28, 2006
Recombinant human granulocyte-colony-stimulating factor-mobilized and apheresis-collected endothelial progenitor cells: a novel blood cell component for therapeutic vasculogenesisMartin Körbling, James M Reuben, Hui Gao, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 26, 2010
Outcomes of patients with myeloid malignancies treated with allogeneic hematopoietic stem cell transplantation from matched unrelated donors compared with one human leukocyte antigen mismatched related donors using HLA typing at 10 lociStefan O Ciurea, Rima M Saliba, Gabriela Rondon, et al.Bone Marrow Transplantation|June 27, 2006
Allogeneic hematopoietic stem cell transplantation after rituximab-containing myeloablative preparative regimen for acute lymphoblastic leukemiaP Kebriaei, R M Saliba, C Ma, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2004
Nonmyeloablative allogeneic hematopoietic transplantation: a promising salvage therapy for patients with non-Hodgkin's lymphoma whose disease has failed a prior autologous transplantationMaricer P Escalón, Richard E Champlin, Rima M Saliba, et al.Pageof 16